Skip to content

Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation

Pilot Project to Determine Rates and Reasons for Non-Adherence in Patients Receiving Chronic Oral Antiarrhythmic Therapy for Atrial Fibrillation in the State of Nebraska

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01513031
Enrollment
9
Registered
2012-01-20
Start date
2012-01-31
Completion date
2012-06-30
Last updated
2012-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Medication Adherence

Keywords

Atrial fibrillation, Anti-arrhythmic medication, Medication adherence

Brief summary

The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.

Interventions

Education related to anti-arrhythmic therapy and monthly telephone follow-up to assess adherence to medication.

Sponsors

Sanofi
CollaboratorINDUSTRY
Creighton University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Prescribed a new anti-arrhythmic medication for atrial fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Adherence to anti-arrhythmic medication1 yearAssessing whether patients stop taking anti-arrhythmic medication without instruction to do so by their physician.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026